274 related articles for article (PubMed ID: 31360108)
1. Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer.
Cheng C; Zhuo S; Zhang B; Zhao X; Liu Y; Liao C; Quan J; Li Z; Bode AM; Cao Y; Luo X
Int J Biol Sci; 2019; 15(8):1654-1663. PubMed ID: 31360108
[TBL] [Abstract][Full Text] [Related]
2. Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease.
Chen Z; Yu Y; Cai J; Li H
Trends Endocrinol Metab; 2019 Dec; 30(12):903-914. PubMed ID: 31597607
[TBL] [Abstract][Full Text] [Related]
3. Natural alkaloid and polyphenol compounds targeting lipid metabolism: Treatment implications in metabolic diseases.
Cheng C; Li Z; Zhao X; Liao C; Quan J; Bode AM; Cao Y; Luo X
Eur J Pharmacol; 2020 Mar; 870():172922. PubMed ID: 31935398
[TBL] [Abstract][Full Text] [Related]
4. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
Geisler CE; Renquist BJ
J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
6. Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases.
Sonnweber T; Pizzini A; Nairz M; Weiss G; Tancevski I
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30360467
[TBL] [Abstract][Full Text] [Related]
7. A review of the studies on food-derived factors which regulate energy metabolism via the modulation of lipid-sensing nuclear receptors.
Goto T
Biosci Biotechnol Biochem; 2019 Apr; 83(4):579-588. PubMed ID: 30572788
[TBL] [Abstract][Full Text] [Related]
8. Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging.
Gong Z; Tas E; Yakar S; Muzumdar R
Mol Cell Endocrinol; 2017 Nov; 455():115-130. PubMed ID: 28017785
[TBL] [Abstract][Full Text] [Related]
9. Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress.
Pai SA; Munshi RP; Panchal FH; Gaur IS; Mestry SN; Gursahani MS; Juvekar AR
Biomed Pharmacother; 2019 Mar; 111():686-694. PubMed ID: 30611993
[TBL] [Abstract][Full Text] [Related]
10. Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context.
Monteillet L; Gjorgjieva M; Silva M; Verzieux V; Imikirene L; Duchampt A; Guillou H; Mithieux G; Rajas F
Mol Metab; 2018 Oct; 16():100-115. PubMed ID: 30100243
[TBL] [Abstract][Full Text] [Related]
11. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
[TBL] [Abstract][Full Text] [Related]
12. Hepatic AMP Kinase as a Potential Target for Treating Nonalcoholic Fatty Liver Disease: Evidence from Studies of Natural Products.
Xu G; Huang K; Zhou J
Curr Med Chem; 2018; 25(8):889-907. PubMed ID: 28393690
[TBL] [Abstract][Full Text] [Related]
13. Modulation of hepatic lipid metabolism by olive oil and its phenols in nonalcoholic fatty liver disease.
Priore P; Cavallo A; Gnoni A; Damiano F; Gnoni GV; Siculella L
IUBMB Life; 2015 Jan; 67(1):9-17. PubMed ID: 25631376
[TBL] [Abstract][Full Text] [Related]
14. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
Parekh S; Anania FA
Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512
[TBL] [Abstract][Full Text] [Related]
15. Insecticide Exposure and Development of Nonalcoholic Fatty Liver Disease.
Yang JS; Park Y
J Agric Food Chem; 2018 Oct; 66(39):10132-10138. PubMed ID: 30193066
[TBL] [Abstract][Full Text] [Related]
16. Fat Mass and Obesity Associated (
Mizuno TM
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30388740
[TBL] [Abstract][Full Text] [Related]
17. [Research progress of stearoyl-CoA desaturase-1 on obesity and non-alcoholic fatty liver disease Abstract].
Chen C; Hu YY; Feng Q
Zhonghua Gan Zang Bing Za Zhi; 2018 Jul; 26(7):545-548. PubMed ID: 30317781
[TBL] [Abstract][Full Text] [Related]
18. The link between Hepatic Vitamin A Metabolism and Nonalcoholic Fatty Liver Disease.
Chen G
Curr Drug Targets; 2015; 16(12):1281-92. PubMed ID: 25808650
[TBL] [Abstract][Full Text] [Related]
19. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
[TBL] [Abstract][Full Text] [Related]
20. Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis.
Musso G; Cassader M; Paschetta E; Gambino R
Gastroenterology; 2018 Aug; 155(2):282-302.e8. PubMed ID: 29906416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
